JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
Wei Xu(Nanjing Medical University), Jianwei Zhou(Nanjing Medical University)
Cited by 58
Related Papers
TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer
|Cell Death and Disease|2014|84
JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis
|Journal of Experimental & Clinical Cancer Research|2020|55
Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib
|Cell & Bioscience|2015|50
miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation
|Oncotarget|2014|43
YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas
|Cancer Cell International|2021|41